Delivery Order SPE2DB25D3017-SPE2DB26FVGSF
Award Date 10/21/25
Potential Completion Date 10/22/25
Potential Value $80K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Mifepristone 300 mg tablets in a 28-day supply quantity, with a ceiling value of $84,653.44. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of September 4, 2025, and performance will occur at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a child contract under the company's broader pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $102,535.75 to AmerisourceBergen Drug Corp for the supply of Mifepristone 300 mg tablets (28-count units) with a completion date of July 30, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and is being performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger indefinite delivery contract (IDC)...
- This is a delivery order awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of mifepristone 300 mg tablets, a medication used for certain medical purposes. The contract has a ceiling value of $81,104.15 and is a firm-fixed-price contract. The contract is not set-aside and is therefore open to full and open competition. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 28-count tablets of the drug mifepristone 300 mg, with a total ceiling value of $44,711.04 and a completion date of June 5, 2025. The contract is a firm fixed-price delivery order and is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Misoprostol 100 microgram tablets in unit dose packaging of 100 units. This competitively awarded, firm fixed-price contract carries a ceiling value of $1,319.56 and is scheduled for completion by September 17, 2025. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX),...
- The Defense Logistics Agency awarded a $3,364.37 firm fixed-price delivery order to AmerisourceBergen Drug Corp for pharmaceutical products on August 22, 2025, with an ultimate completion date of August 25, 2025. The delivery order covers Myfembree 40 mg–1 mg–0.5 mg tablets in a 28-day supply, a hormonal contraceptive medication. This is a non-set-aside competitive award issued against AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a...
- The Defense Logistics Agency awarded a $1,437.52 delivery order to AmerisourceBergen Drug Corp on October 17, 2025, for the supply of Megestrol 625 mg/5 ml suspension in a 150 ml quantity. This firm fixed-price delivery order, which is not set-aside and competitively awarded, is scheduled for completion by October 20, 2025, with performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a child contract under a larger vehicle structure, enabling the company...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a competitive delivery order valued at $2,324.60 from the Defense Logistics Agency's Medical Supply Chain on September 4, 2025. Designated as a firm fixed-price contract with no set-aside provisions, this delivery order is structured as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00...
- The Defense Logistics Agency awarded a delivery order valued at $5,316.97 to AmerisourceBergen Drug Corp for pharmaceutical supplies, specifically Myfembree 40 mg, 1 mg, and 0.5 mg tablets in a 28-count package. The contract is a firm fixed price delivery order with no set-aside designation, issued on September 22, 2025, with an ultimate completion date of September 23, 2025. Performance will be executed at AmerisourceBergen's Conshohocken, Pennsylvania facility, which serves as the company's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for methylergonovine 0.2 mg/mL, a pharmaceutical product used in obstetric care, valued at $5,983.20 with a firm fixed price structure. The contract, which was competitively awarded without set-aside designation, was executed on September 15, 2025, with an ultimate completion date of September 16, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains...